BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26224810)

  • 1. Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve.
    Bouchareb R; Mahmut A; Nsaibia MJ; Boulanger MC; Dahou A; Lépine JL; Laflamme MH; Hadji F; Couture C; Trahan S; Pagé S; Bossé Y; Pibarot P; Scipione CA; Romagnuolo R; Koschinsky ML; Arsenault BJ; Marette A; Mathieu P
    Circulation; 2015 Aug; 132(8):677-90. PubMed ID: 26224810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease.
    Mathieu P; Boulanger MC
    Front Cardiovasc Med; 2019; 6():18. PubMed ID: 30881959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiology of Lp(a) in calcific aortic valve disease.
    Mathieu P; Arsenault BJ; Boulanger MC; Bossé Y; Koschinsky ML
    Expert Rev Cardiovasc Ther; 2017 Oct; 15(10):797-807. PubMed ID: 28816078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
    Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
    J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
    Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
    J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid substance within stenotic aortic valves promotes mineralization.
    Audet A; Côté N; Couture C; Bossé Y; Després JP; Pibarot P; Mathieu P
    Histopathology; 2012 Oct; 61(4):610-9. PubMed ID: 22642224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.
    Bouchareb R; Boulanger MC; Tastet L; Mkannez G; Nsaibia MJ; Hadji F; Dahou A; Messadeq Y; Arsenault BJ; Pibarot P; Bossé Y; Marette A; Mathieu P
    Eur Heart J; 2019 May; 40(17):1362-1373. PubMed ID: 30395215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis.
    Bourgeois R; Devillers R; Perrot N; Després AA; Boulanger MC; Mitchell PL; Guertin J; Couture P; Boffa MB; Scipione CA; Pibarot P; Koschinsky ML; Mathieu P; Arsenault BJ
    JACC Basic Transl Sci; 2020 Sep; 5(9):888-897. PubMed ID: 33015412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway.
    Nsaibia MJ; Boulanger MC; Bouchareb R; Mkannez G; Le Quang K; Hadji F; Argaud D; Dahou A; Bossé Y; Koschinsky ML; Pibarot P; Arsenault BJ; Marette A; Mathieu P
    Cardiovasc Res; 2017 Sep; 113(11):1351-1363. PubMed ID: 28472283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells.
    Yoon D; Choi B; Kim JE; Kim EY; Chung SH; Min HJ; Sung Y; Chang EJ; Song JK
    BMC Med; 2024 Mar; 22(1):122. PubMed ID: 38486246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease.
    El Husseini D; Boulanger MC; Mahmut A; Bouchareb R; Laflamme MH; Fournier D; Pibarot P; Bossé Y; Mathieu P
    J Mol Cell Cardiol; 2014 Jul; 72():146-56. PubMed ID: 24631773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr
    Scatena M; Jackson MF; Speer MY; Leaf EM; Wallingford MC; Giachelli CM
    Cardiovasc Pathol; 2018; 34():28-37. PubMed ID: 29539583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Not-So-Little Role for Lipoprotein(a) in the Development of Calcific Aortic Valve Disease.
    Rogers MA; Aikawa E
    Circulation; 2015 Aug; 132(8):621-3. PubMed ID: 26224809
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis.
    Schnitzler JG; Ali L; Groenen AG; Kaiser Y; Kroon J
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.
    Mahmut A; Boulanger MC; Bouchareb R; Hadji F; Mathieu P
    Cardiovasc Res; 2015 Apr; 106(1):109-20. PubMed ID: 25644539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a): Expanding our knowledge of aortic valve narrowing.
    Youssef A; Clark JR; Koschinsky ML; Boffa MB
    Trends Cardiovasc Med; 2021 Jul; 31(5):305-311. PubMed ID: 32525013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.
    Torzewski M; Ravandi A; Yeang C; Edel A; Bhindi R; Kath S; Twardowski L; Schmid J; Yang X; Franke UFW; Witztum JL; Tsimikas S
    JACC Basic Transl Sci; 2017 Jun; 2(3):229-240. PubMed ID: 29147686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoC-III is a novel inducer of calcification in human aortic valves.
    Schlotter F; de Freitas RCC; Rogers MA; Blaser MC; Wu PJ; Higashi H; Halu A; Iqbal F; Andraski AB; Rodia CN; Kuraoka S; Wen JR; Creager M; Pham T; Hutcheson JD; Body SC; Kohan AB; Sacks FM; Aikawa M; Singh SA; Aikawa E
    J Biol Chem; 2021; 296():100193. PubMed ID: 33334888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical strain induces the production of spheroid mineralized microparticles in the aortic valve through a RhoA/ROCK-dependent mechanism.
    Bouchareb R; Boulanger MC; Fournier D; Pibarot P; Messaddeq Y; Mathieu P
    J Mol Cell Cardiol; 2014 Feb; 67():49-59. PubMed ID: 24368096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
    Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.